726 related articles for article (PubMed ID: 18481824)
1. Transplantation of urokinase-type plasminogen activator gene-modified bone marrow-derived liver stem cells reduces liver fibrosis in rats.
Sun C; Li DG; Chen YW; Chen YW; Wang BC; Sun QL; Lu HM
J Gene Med; 2008 Aug; 10(8):855-66. PubMed ID: 18481824
[TBL] [Abstract][Full Text] [Related]
2. [Effects of gene-transfected bone marrow-derived liver stem cell transplantation on accumulation of extracellular matrix in rats with liver fibrosis].
Sun C; Li DG; Chen YW; Chen YW; Wang BC
Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(38):2685-9. PubMed ID: 19080687
[TBL] [Abstract][Full Text] [Related]
3. Treatment of experimental hepatic fibrosis by combinational delivery of urokinase-type plasminogen activator and hepatocyte growth factor genes.
Lin Y; Xie WF; Chen YX; Zhang X; Zeng X; Qiang H; Chen WZ; Yang XJ; Han ZG; Zhang ZB
Liver Int; 2005 Aug; 25(4):796-807. PubMed ID: 15998431
[TBL] [Abstract][Full Text] [Related]
4. Human urokinase-type plasminogen activator gene-modified bone marrow-derived mesenchymal stem cells attenuate liver fibrosis in rats by down-regulating the Wnt signaling pathway.
Ma ZG; Lv XD; Zhan LL; Chen L; Zou QY; Xiang JQ; Qin JL; Zhang WW; Zeng ZJ; Jin H; Jiang HX; Lv XP
World J Gastroenterol; 2016 Feb; 22(6):2092-103. PubMed ID: 26877613
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells.
Hu PF; Zhu YW; Zhong W; Chen YX; Lin Y; Zhang X; Yin C; Yue HY; Xie WF
J Gastroenterol Hepatol; 2008 Dec; 23(12):1917-25. PubMed ID: 18761555
[TBL] [Abstract][Full Text] [Related]
6. Urokinase-type plasminogen activator gene therapy in liver cirrhosis is mediated by collagens gene expression down-regulation and up-regulation of MMPs, HGF and VEGF.
Bueno M; Salgado S; Beas-Zárate C; Armendariz-Borunda J
J Gene Med; 2006 Nov; 8(11):1291-9. PubMed ID: 16958060
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effect of transplanting beta(2)m(-)/Thy1(+) bone marrow-derived hepatocyte stem cells transduced with lentiviral-mediated HGF gene into CCl(4)-injured rats.
Hu JJ; Sun C; Lan L; Chen YW; Li DG
J Gene Med; 2010 Mar; 12(3):244-54. PubMed ID: 20143305
[TBL] [Abstract][Full Text] [Related]
8. Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy.
Salgado S; Garcia J; Vera J; Siller F; Bueno M; Miranda A; Segura A; Grijalva G; Segura J; Orozco H; Hernandez-Pando R; Fafutis M; Aguilar LK; Aguilar-Cordova E; Armendariz-Borunda J
Mol Ther; 2000 Dec; 2(6):545-51. PubMed ID: 11124055
[TBL] [Abstract][Full Text] [Related]
9. [Effect of interleukin 10 gene-modified bone marrow-derived liver stem cells transplantation on hepatic inflammatory response and liver regeneration in hepatic fibrosis rats].
Lan L; Chen YW; Sun C; Liu BW; Sun QL; Li DG
Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):915-20. PubMed ID: 20038333
[TBL] [Abstract][Full Text] [Related]
10. Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesis in rats.
Hu YB; Li DG; Lu HM
J Gene Med; 2007 Mar; 9(3):217-29. PubMed ID: 17351970
[TBL] [Abstract][Full Text] [Related]
11. Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat.
Abe W; Ikejima K; Lang T; Okumura K; Enomoto N; Kitamura T; Takei Y; Sato N
J Hepatol; 2007 Feb; 46(2):286-94. PubMed ID: 17166617
[TBL] [Abstract][Full Text] [Related]
12. [The plasma levels of transforming growth factor beta1 and the protein expressions of alpha-SMA, urokinase plasminogen activator and plasminogen activator inhibitor-1 in liver of patients with different grades of hepatic fibrosis].
Wu XR; Lv MH; Wang Q; Shi SS; Guo WD
Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):400-2. PubMed ID: 15268802
[TBL] [Abstract][Full Text] [Related]
13. Intrasplenic transplantation of syngenic hepatocytes modified by IFN-gamma gene ameliorates hepatic fibrosis in rats.
Song E; Chen J; Wang K; Zhang H; Su F; Wang M; Heemann U
Transpl Int; 2002 Oct; 15(9-10):472-8. PubMed ID: 12389079
[TBL] [Abstract][Full Text] [Related]
14. Significance and therapeutic potential of endothelial progenitor cell transplantation in a cirrhotic liver rat model.
Nakamura T; Torimura T; Sakamoto M; Hashimoto O; Taniguchi E; Inoue K; Sakata R; Kumashiro R; Murohara T; Ueno T; Sata M
Gastroenterology; 2007 Jul; 133(1):91-107.e1. PubMed ID: 17631135
[TBL] [Abstract][Full Text] [Related]
15. Fraxinus rhynchophylla ethanol extract attenuates carbon tetrachloride-induced liver fibrosis in rats via down-regulating the expressions of uPA, MMP-2, MMP-9 and TIMP-1.
Peng WH; Tien YC; Huang CY; Huang TH; Liao JC; Kuo CL; Lin YC
J Ethnopharmacol; 2010 Feb; 127(3):606-13. PubMed ID: 20035854
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte nuclear factor 4alpha attenuates hepatic fibrosis in rats.
Yue HY; Yin C; Hou JL; Zeng X; Chen YX; Zhong W; Hu PF; Deng X; Tan YX; Zhang JP; Ning BF; Shi J; Zhang X; Wang HY; Lin Y; Xie WF
Gut; 2010 Feb; 59(2):236-46. PubMed ID: 19671543
[TBL] [Abstract][Full Text] [Related]
17. Genistein modifies liver fibrosis and improves liver function by inducing uPA expression and proteolytic activity in CCl4-treated rats.
Salas AL; Montezuma TD; Fariña GG; Reyes-Esparza J; Rodríguez-Fragoso L
Pharmacology; 2008; 81(1):41-9. PubMed ID: 17823541
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated inhibition of SPARC attenuates liver fibrosis in rats.
Camino AM; Atorrasagasti C; Maccio D; Prada F; Salvatierra E; Rizzo M; Alaniz L; Aquino JB; Podhajcer OL; Silva M; Mazzolini G
J Gene Med; 2008 Sep; 10(9):993-1004. PubMed ID: 18615449
[TBL] [Abstract][Full Text] [Related]
19. Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice.
Higashiyama R; Moro T; Nakao S; Mikami K; Fukumitsu H; Ueda Y; Ikeda K; Adachi E; Bou-Gharios G; Okazaki I; Inagaki Y
Gastroenterology; 2009 Oct; 137(4):1459-66.e1. PubMed ID: 19596008
[TBL] [Abstract][Full Text] [Related]
20. Extracellular matrix deposition, lysyl oxidase expression, and myofibroblastic differentiation during the initial stages of cholestatic fibrosis in the rat.
Desmoulière A; Darby I; Costa AM; Raccurt M; Tuchweber B; Sommer P; Gabbiani G
Lab Invest; 1997 Jun; 76(6):765-78. PubMed ID: 9194853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
